Skip to main content
. 2013 Sep 4;6(5):1245–1252. doi: 10.3892/ol.2013.1563

Figure 5.

Figure 5

Prostate-specific antigen (PSA) recurrence-free survival stratified for p27 staining score in (A) all prostate cancers, as compared with subsets of (B) ERG fusion-negative and (C) ERG fusion-positive prostate cancers.